🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Biliary Tract Neoplasms

Histotripsy in Biliary Tract Cancer NCT07853690NA1 site📍 New York NYU Langone Health · Tests: Gemcitabine, Cisplatin, Durvalumab, Pembrolizumab, Histotripsy A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib Personalized Medicine for Advanced Biliary Cancer Patients NCT05615818Phase 369 sites📍 Brussels📍 Brussels📍 Edegem UNICANCER · Tests: Futibatinib, Ivosidenib, Zanidatamab, Trastuzumab, Neratinib AB122 Platform Study NCT04999761Phase 19 sites📍 Aichi📍 Chiba📍 Ehime Taiho Pharmaceutical Co., Ltd. · Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies NCT06181032Phase 11 site📍 Fuzhou First Affiliated Hospital of Fujian Medical University · Tests: Adebrelimab, Apatinib, Gemcitabine, Cisplatin Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer NCT07267078Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Tuvonralimab/Iparomlimab combination with GEMOX chemotherapy NGS in Gallbladder Cancer and Response to Treatment NCT05404347n/a1 site📍 Varanasi Banaras Hindu University · Tests: Next generation sequencing Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room NCT07473687n/a1 site📍 Taipei Taipei Veterans General Hospital, Taiwan · Tests: Non-contact rPPG software Efficacy of Fistulotomy for Biliary Cannulation NCT04037007NA1 site📍 Mexico City Coordinación de Investigación en Salud, Mexico · Tests: Fistulotomy - High experienced., Fistulotomy - Low experienced., Conventional (guidewire) cannulation- High experienced… A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites📍 Hangzhou📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: CEA-targeted CAR-T cells Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) NCT06564623Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: mBTC vax [0.3 - 2.4 mg peptide + 0.5 mg Poly-ICLC (Hiltonol)], Durvalumab, Tremelimumab Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients NCT07673861NA1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Marsden360 ctDNA test and GTAB review Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors NCT05784688Phase 1, Phase 211 sites📍 San Antonio📍 Tyler📍 Spokane TiumBio Co., Ltd. · Tests: TU2218 + KEYTRUDA® (Pembrolizumab) Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) NCT07161869n/a6 sites📍 Rotterdam📍 Amsterdam📍 Groningen Erasmus Medical Center · Tests: Registration of all findings during preoperative Endoscopic Ultrasound Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma NCT05874414Phase 1, Phase 211 sites📍 Los Angeles📍 Los Angeles📍 Orlando Genfit · Tests: GNS561 + Trametinib Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer NCT07636798Phase 1, Phase 21 site📍 Chengdu West China Hospital · Tests: HAIC Combined Regimen Treatment Group CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers NCT06548412Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Gemcitabine, Cisplatin, Durvalumab, CTX-009 Incidental Gallbladder Carcinoma :Incidence and Clinical Significance in Specimens From Routine Cholecystectomies in Sohag Locality NCT07885800n/a1 site📍 Sohag Sohag University · Tests: histopathology of gall bladder Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer NCT07025174Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: PD-1/CTLA-4 Dual Functional Antibody, Gemcitabine, Cisplatin, Anlotinib, Oxaliplatin + 5-Fluorouracil/Leucovorin MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer NCT07156058NA1 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: MiniPDX group, Capecitabine Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors NCT06975410Phase 1, Phase 24 sites📍 Seoul📍 Seoul📍 Seoul Yuhan Corporation · Tests: YH32364 PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI NCT05172310Phase 11 site📍 Stockholm Karolinska University Hospital · Tests: 68Ga-FAPI-46, PET/CT Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients NCT07062263Phase 36 sites📍 Muzaffarpur📍 Mumbai📍 Bhubaneswar Tata Memorial Centre · Tests: Trastuzumab, Chemotherapy A Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction NCT07530354n/a3 sites📍 Wuhan📍 Wuhan📍 Wuhan Wuhan Children's Hospital Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer NCT07704177Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Trastuzumab Rezetecan, Adebrelimab, Lenvatinib Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) NCT04611867NA1 site📍 Herlev Inna Chen, MD · Tests: Supportive application with integrated weekly PRO A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site📍 Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. · Tests: INV-8989
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy